|Chart | Calendar   | TRADE NOW |Johnson & Johnson Johnson & Johnson to seek approval for 10 potential blockbusters in next 4 years BUZ INVESTORS  Johnson & Johnson to seek approval Johnson & Johnson (JNJ), -0.41% said Wednesday that it, along with its Janssen Pharmaceutical Companies, plans to file for regulatory approval 10 new potential blockbuster
Complete Reading

Nemaska Lithium CEO on the “very strong message” behind the Johnson Matthey deal THE BUZ ON LITHIUM Buz Investors Nemaska Lithium In a special InvestorIntel interview, Publisher Tracy Weslosky speaks with Guy Bourassa, President, CEO and Director for Nemaska Lithium Inc. (TSXV:NMX | OTCQX:NMKEF) about the 166% increase in stock in 2015 and the Johnson
Complete Reading

Forget Johnson & Johnson: This Name Has WAY More Upside Than JNJ Stock Buz Trader Alert  More Upside Than JNJ  Johnson & Johnson (NYSE:JNJ) has always been a trusted name for anyone who has ever sought out any type of medical or personal care product, including shampoo,  bandages, and over-the-counter medications. Johnson & Johnson operates with three
Complete Reading

Johnson & Johnson: 1 Dividend inventory to own all the time Investors Buz   –    Global Markets Roundup Johnson and Johnson: A strong Dividend pick Healthcare and customer items companies may not sound as interesting as internet ones, however in this extremely-low hobby fee surroundings, it can be profitable to check Johnson & Johnson
Complete Reading

Create Account



Log In Your Account